Copy
New and Notable Evidence 2021
View this email in your browser
Trusted evidence. Informed decisions. Better health.

New and Notable Evidence | February 2021

Listing of articles does not imply recommendation.
Please forward this email to anyone you think would be interested in it!

Content:

Abortion 

Trials
Dilation and curettage versus operative hysteroscopy for missed abortion  (https://clinicaltrials.gov/show/NCT04705324) registered January 2021

Dragoman MV, Grossman D, Nguyen MH, Habib N, Kapp N, Tamang A, Bessenaar T, Duong LD, Gautam J, Yoko JL, Hong M, Gulmezoglu M. Two prophylactic pain management regimens for medical abortion ≤63 days' gestation with mifepristone and misoprostol: A multicenter, randomized, placebo-controlled trial. Contraception. 2020 Dec 29:S0010-7824(20)30441-8.
DOI: 10.1016/j.contraception.2020.12.004. PMID: 33451721

Reviews
Filippi V, Dennis M, Calvert C, Tunçalp Ö, Ganatra B, Kim CR, Ronsmans C. Abortion metrics: a scoping review of abortion measures and indicators. BMJ Glob Health. 2021 Jan;6(1):e003813. doi: 10.1136/bmjgh-2020-003813. PMID: 33514592

Mekie M, Addisu D, Dagnew E, Necho W. The level and deriving factors of repeat-induced abortion in Ethiopia: A systematic review and meta-analysis. Heliyon. 2021 Jan 16;7(1):e05984. doi: 10.1016/j.heliyon.2021.e05984. PMID: 33506136

O'Shea LE, Lohr PA, Lord J, Hasler E, Cameron S. Cervical priming before surgical abortion between 14 and 24 weeks: a systematic review and meta-analyses for the National Institute for Health and Care Excellence-new clinical guidelines for England. Am J Obstet Gynecol MFM. 2021 Jan;3(1):100283. doi: 10.1016/j.ajogmf.2020.100283. PMID: 33451604

Contraception 

Trials
Dings SJM, van Stralen KJ, Struben VMD, Noordzij MA. Pain and anxiety during vasectomies while distracting patients with video glasses or virtual reality glasses. BJU Int. 2021 Jan 2. doi: 10.1111/bju.15332. PMID: 33387391

Halpern V, Brache V, Taylor D, Lendvay A, Cochón L, Jensen JT, Dorflinger LJ. Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-Provera. Fertil Steril. 2021 Jan 20:S0015-0282(20)32669-8. doi: 10.1016/j.fertnstert.2020.11.002. PMID: 33485608

Hopelian NG, Simmons RG, Sanders JN, Ward K, Jenkins SM, Espey E, Turok DK. Comparison of levonorgestrel level and creamatocrit in milk following immediate versus delayed postpartum placement of the levonorgestrel IUD. BMC Womens Health. 2021 Jan 21;21(1):33. doi: 10.1186/s12905-021-01179-7. PMID: 33478494

Hylton-Kong T, Steiner MJ, Bailey A, Palazzi M, Gallo MF. Debunking myths about contraceptive safety among women in Kingston, Jamaica: Pilot randomized controlled trial. Contraception. 2021 Jan 9:S0010-7824(21)00003-2. doi: 10.1016/j.contraception.2020.12.016. PMID: 33428906

Klipping C, Duijkers I, Mawet M, Maillard C, Bastidas A, Jost M, Foidart JM.Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone. Contraception. 2021 Jan 9:S0010-7824(21)00002-0. doi: 10.1016/j.contraception.2021.01.001. PMID: 33428907 

Lee JK, Burke AE, Thaler K, Robinson JA, Sufrin C. Oral sedation for pain with cervical dilator placement: a randomized controlled trial. Contracept X. 2021 Jan 7;3:100053. doi: 10.1016/j.conx.2020.100053. PMID: 33506195

Marangoni M Jr, Laporte M, Surita F, Kraft MB, Bahamondes L, Juliato CRT. One-year follow-up on post-placental IUD insertion: A randomized clinical trial. Acta Obstet Gynecol Scand. 2021 Jan 9. doi: 10.1111/aogs.14081. PMID: 33421091

Martin D, Cooper Simon B, Tang JCY, Fraser WD, Sale C, Elliott-Sale KJ. Bone metabolic marker concentrations across the menstrual cycle and phases of combined oral contraceptive use. Bone. 2021 Jan 25:115864. doi: 10.1016/j.bone.2021.115864. PMID: 33508495

Martin D, Papageorgiou M, Colgan H, Bandelow S, Greeves J, Tang JCY, Fraser W, Cooper SB, Sale C, Elliott-Sale KJ. The effects of short-term low energy availability, achieved through diet or exercise, on cognitive function in oral contraceptive users and eumenorrheic women. Appl Physiol Nutr Metab. 2021 Jan 5. doi: 10.1139/apnm-2020-0474. PMID: 33400618

Myllyaho MM, Ihalainen JK, Hackney AC, Valtonen M, Nummela A, Vaara E, Häkkinen K, Kyröläinen H, Taipale RS. Hormonal Contraceptive Use Does Not Affect Strength, Endurance, or Body Composition Adaptations to Combined Strength and Endurance Training in Women. J Strength Cond Res. 2021 Feb 1;35(2):449-457. doi: 10.1519/JSC.0000000000002713. PMID: 29927884

Singata-Madliki M, Carayon-Lefebvre d'Hellencourt F, Lawrie TA, Balakrishna Y, Hofmeyr GJ. Effects of three contraceptive methods on depression and sexual function: An ancillary study of the ECHO* randomized trial. Int J Gynaecol Obstet. 2021 Jan 14. doi: 10.1002/ijgo.13594. PMID: 33448029

Turok DK, Gero A, Simmons RG, Kaiser JE, Stoddard GJ, Sexsmith CD, Gawron LM, Sanders JN. Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception. N Engl J Med. 2021 Jan 28;384(4):335-344. doi: 10.1056/NEJMoa2022141. PMID: 33503342

Wagner GJ, Mindry D, Hurley EA, Beyeza-Kashesya J, Gwokyalya V, Finocchario-Kessler S, Wanyenze RK, Nanfuka M, Tebeka MG, Goggin K. Reproductive intentions and corresponding use of safer conception methods and contraception among Ugandan HIV clients in serodiscordant relationships. BMC Public Health. 2021 Jan 19;21(1):156. doi: 10.1186/s12889-021-10163-7. PMID: 33468072

Reviews
Moray KV, Chaurasia H, Sachin O, Joshi B. A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant. Reprod Health. 2021 Jan 6;18(1):4. doi: 10.1186/s12978-020-01054-y. PMID: 33407632

Zulu EM, Sukwa T. Impact of mHealth on contraceptive use among women and men of reproductive age in low- and middle-income countries: a systematic review and meta-analysis. Trop Med Int Health. 2020 Oct;25(10):1182-1197. doi: 10.1111/tmi.13464. PMID: 33463875 

Family Planning 

Reviews
Ouedraogo L, Habonimana D, Nkurunziza T, Chilanga A, Hayfa E, Fatim T, Kidula N, Conombo G, Muriithi A, Onyiah P. Towards achieving the family planning targets in the African region: a rapid review of task sharing policies. Reprod Health. 2021 Jan 23;18(1):22. doi: 10.1186/s12978-020-01038-y. PMID: 33485339

Paynter M, Heggie C, McKibbon S, Martin-Misener R, Iftene A, Murphy GT. Sexual and Reproductive Health Outcomes among Incarcerated Women in Canada: A Scoping Review. Can J Nurs Res. 2021 Jan 28:844562120985988. doi: 10.1177/0844562120985988. PMID: 33508956
 
Listing of articles does not imply recommendation.
Please forward this email to anyone you think would be interested in it!


New & Notable Evidence is a free monthly email service of the
Cochrane Fertility Regulation Review Group

 
Keep up to date and subscribe here!
Website
Website
Twitter
Twitter
Email
Email
Copyright © 2021 Cochrane Fertility Regulation Group, All rights reserved.


unsubscribe from this list    update subscription preferences 

Please note: unsubscribing will remove you from the Cochrane Fertility Regulation Group's mailing list, but it will not automatically unsubscribe you from other Cochrane Groups' mailing lists or from Cochrane’s organizational mailing lists which you can manage at account.cochrane.org.

Email Marketing Powered by Mailchimp